Why the study?
Does ivabradine improve post-COVID-19 inadequate sinus tachycardia and exercise intolerance in a 36-year-old man?
Case Report (n=1)
Does ivabradine improve post-COVID-19 inadequate sinus tachycardia and exercise intolerance in a 36-year-old man?
Ivabradine may be a treatment option for inadequate sinus tachycardia and exercise intolerance following COVID-19 infection.
Treatment of inadequate sinus tachycardia starting with COVID-19 in 36-year-old men with ivabradine is presented. The author describes this complication of post-COVID-19 palpitations. exercise intolerance and the possible treatments.
No takes yet. Share an insight, caveat, or question.
János Tomcsányi (2021) conducted a case report in Post-COVID-19 inadequate sinus tachycardia (n=1). Ivabradine was evaluated on Heart rate reduction and symptom relief.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: